Literature DB >> 28864449

Feasibility and acceptability of a patient-reported outcome intervention in chronic heart failure.

Pauline M Kane1, Barbara A Daveson1, Karen Ryan2, Clare I Ellis-Smith1, Niall G Mahon3, Brendan McAdam4, Regina McQuilllan, Cecelia Tracey3, Christine Howley3, Geraldine O'Gara4, Caroline Raleigh4, Irene J Higginson1, Jonathan Koffman1, Fliss E M Murtagh1,5.   

Abstract

Patients with chronic heart failure (CHF) have symptoms and concerns which are inadequately addressed. Patient-reported outcome measures (PROMs) can potentially improve the identification and management of advanced symptoms and palliative concerns. However, these have not been used in CHF.
OBJECTIVES: To examine the feasibility and acceptability of using a PROM-the Integrated Palliative care Outcome Scale (IPOS)-together with heart failure nurse education and training to improve the identification and management of symptoms and concerns among patients with CHF.
METHODS: A parallel, mixed methods design with an embedded qualitative component was used to examine the feasibility of recruitment, retention, intervention adherence/compliance and follow-up assessment completion (symptom burden, quality of life, psychological well-being). Patient and nurse qualitative semistructured interviews explored intervention and study design feasibility and its acceptability.
RESULTS: Conversion to consent was 46.9% (372 screened, 81 approached, 38 recruited). 66% of patient participants completed the IPOS; 6% of IPOS questionnaire items were missing (non-response). Over two-thirds (65.6%) of these missing items related to three patients. No item was consistently missing; appetite was the most frequent missing item (1.4%). 92% of participants who completed the IPOS completed all follow-up assessments (1-2 days, 1-2 weeks and 4-6 weeks post-IPOS completion) with no missing data. The a priori feasibility objectives were met. Patients and nurses reported the intervention and study design feasible and acceptable.
CONCLUSIONS: A palliative-specific PROM-based intervention is feasible and acceptable to both patients with CHF and nurses in nurse-led disease management clinics for the purposes of both clinical care and research. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  acceptability; feasibility; heart failure; palliative care; patient-reported outcome measure

Mesh:

Year:  2017        PMID: 28864449     DOI: 10.1136/bmjspcare-2017-001355

Source DB:  PubMed          Journal:  BMJ Support Palliat Care        ISSN: 2045-435X            Impact factor:   3.568


  14 in total

1.  Comprehensive symptom assessment using Integrated Palliative care Outcome Scale in hospitalized heart failure patients.

Authors:  Yasuhiro Hamatani; Moritake Iguchi; Yurika Ikeyama; Atsuko Kunugida; Megumi Ogawa; Natsushige Yasuda; Kana Fujimoto; Hidenori Ichihara; Misaki Sakai; Tae Kinoshita; Yasuyo Nakashima; Masaharu Akao
Journal:  ESC Heart Fail       Date:  2022-03-20

2.  Implementing advance care planning in heart failure: a qualitative study of primary healthcare professionals.

Authors:  Markus Schichtel; John I MacArtney; Bee Wee; Anne-Marie Boylan
Journal:  Br J Gen Pract       Date:  2021-06-24       Impact factor: 6.302

3.  Examining Adherence and Dose Effect of an Early Palliative Care Intervention for Advanced Heart Failure Patients.

Authors:  Rachel Wells; James Nicholas Dionne-Odom; Andres Azuero; Harleah Buck; Deborah Ejem; Kathryn L Burgio; Macy L Stockdill; Rodney Tucker; Salpy V Pamboukian; Jose Tallaj; Sally Engler; Konda Keebler; Sheri Tims; Raegan Durant; Keith M Swetz; Marie Bakitas
Journal:  J Pain Symptom Manage       Date:  2021-02-05       Impact factor: 5.576

4.  What to consider when implementing a tool for timely recognition of palliative care needs in heart failure: a context-based qualitative study.

Authors:  Stephanie M C Ament; Lisette M van den Broek; Marieke H J van den Beuken-van Everdingen; Josiane J J Boyne; José M C Maessen; Sebastiaan C A M Bekkers; Louise Bellersen; Hans-Peter Brunner-La Rocca; Yvonne Engels; Daisy J A Janssen
Journal:  BMC Palliat Care       Date:  2022-01-04       Impact factor: 3.234

5.  An Evidence-Based Theory About PRO Use in Kidney Care: A Realist Synthesis.

Authors:  Kara Schick-Makaroff; Adrienne Levay; Stephanie Thompson; Rachel Flynn; Richard Sawatzky; Onouma Thummapol; Scott Klarenbach; Mehri Karimi-Dehkordi; Joanne Greenhalgh
Journal:  Patient       Date:  2021-06-10       Impact factor: 3.883

6.  Early integrated palliative care in chronic heart failure and chronic obstructive pulmonary disease: protocol of a feasibility before-after intervention study.

Authors:  N Siouta; A Heylen; B Aertgeerts; P Clement; J Van Cleemput; W Janssens; J Menten
Journal:  Pilot Feasibility Stud       Date:  2019-02-21

7.  Psychometric properties of the Czech Integrated Palliative Outcome Scale: reliability and content validity analysis.

Authors:  Karolina Vlckova; Eva Hoschlova; Eva Chroustova; Martin Loucka
Journal:  BMC Palliat Care       Date:  2020-03-25       Impact factor: 3.234

8.  Tools to help healthcare professionals recognize palliative care needs in patients with advanced heart failure: A systematic review.

Authors:  Stephanie Mc Ament; Inge Me Couwenberg; Josiane Jj Boyne; Jos Kleijnen; Henri Ejh Stoffers; Marieke Hj van den Beuken; Yvonne Engels; Louise Bellersen; Daisy Ja Janssen
Journal:  Palliat Med       Date:  2020-10-15       Impact factor: 4.762

Review 9.  Palliative Care in Acute Heart Failure.

Authors:  James M Beattie; Irene J Higginson; Theresa A McDonagh
Journal:  Curr Heart Fail Rep       Date:  2020-10-29

Review 10.  Palliative care needs-assessment and measurement tools used in patients with heart failure: a systematic mixed-studies review with narrative synthesis.

Authors:  Bader Nael Remawi; Amy Gadoud; Iain Malcolm James Murphy; Nancy Preston
Journal:  Heart Fail Rev       Date:  2021-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.